tiprankstipranks
Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX
US Market
PCRX
Pacira Pharmaceuticals
RESEARCH TOOLSreports
Want to see PCRX full AI Analyst Report?

Pacira Pharmaceuticals (PCRX) Stock News & Sentiment

384 Followers
Pacira Earnings Call Highlights Growth, Pipeline Momentum
Premium
Company Announcements
Pacira Earnings Call Highlights Growth, Pipeline Momentum
2d ago
PCRX
AI Models Turn More Positive on Pacira Pharmaceuticals as Cash Flow and Balance Sheet Strength Offset Valuation Concerns
Premium
AI Analyst Ratings
AI Models Turn More Positive on Pacira Pharmaceuticals as Cash Flow and Balance Sheet Strength Offset Valuation Concerns
2d ago
PCRX
PCRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
PCRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5d ago
PCRX
Exparel’s Proven Clinical and Economic Value Underpins Buy Rating and $38 Price Target on Pacira BioSciences
Premium
Ratings
Exparel’s Proven Clinical and Economic Value Underpins Buy Rating and $38 Price Target on Pacira BioSciences
20d ago
PCRX
Pacira Earnings Call Highlights Margin Gains And Growth
Premium
Company Announcements
Pacira Earnings Call Highlights Margin Gains And Growth
2M ago
PCRX
Pacira: Conservative 2026 Outlook, Margin Discipline, and NOPAIN Act Tailwinds Support Buy Rating
Premium
Ratings
Pacira: Conservative 2026 Outlook, Margin Discipline, and NOPAIN Act Tailwinds Support Buy Rating
2M ago
PCRX
PCRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
PCRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
PCRX
More PCRX News >

PCRX News on the Web

H.C. Wainwright Reaffirms Their Buy Rating on Pacira Pharmaceuticals (PCRX)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: QuidelOrtho (QDEL), Pacira Pharmaceuticals (PCRX) and Personalis (PSNL)
TipRanks News
Bullish
Exparel’s Proven Clinical and Economic Value Underpins Buy Rating and $38 Price Target on Pacira BioSciences
TipRanks News
Bullish
Pacira real-world data clearer in hip arthroplasty, says H.C. Wainwright
TipRanks News
Bullish
Pacira presents data showing lower healthcare costs for Exparel
TipRanks News
Bullish
Pacira price target lowered to $25 from $27 at Barclays
TipRanks News
Neutral
Analysts Conflicted on These Healthcare Names: Vertex Pharmaceuticals (VRTX), Pacira Pharmaceuticals (PCRX) and Alnylam Pharma (ALNY)
TipRanks News
Neutral
J.P. Morgan Sticks to Their Sell Rating for Pacira Pharmaceuticals (PCRX)
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
PCRX
Sector Average
Media Buzz
This Week1 articles
Weekly Average2 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PCRX’s Media Buzz Sentiment?
1 articles about PCRX were published this week. In an average week, 2 articles are published.
    What is PCRX’s weekly average amount of articles?
    In an average week, 2 articles about PCRX are published.
      What is PCRX’s News Sentiment?
      100% of articles about PCRX were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week